|
|
Clinical value of morphological examination of bone marrow cells in the identification of refractory anemia and megaloblastic anemia |
YUAN Xiao-feng |
Department of Clinical Laboratory,the 97thHospital of PLA,Jiangsu Province,Xuzhou 221000,China |
|
|
Abstract ObjectiveTo compare and analyze the clinical value of morphological examination of bone marrow cells in the identification of refractory anemia and megaloblastic anemia.Methods64 anemia patients treated in our hospital from October 2013 to October 2016 were selected as observation objects,and 32 cases were refractory anemia,32 cases were megaloblastic anemia.Participants in the two groups were all provided with the clinical test of morphological examination of bone marrow cells,and test results were analyzed and compared.ResultsIn the refractory anemia group,the positivity rate of PAS was 71.88%,the proportion rates of erythroid pathosis,granulocytic pathosis,and lymphoid megakaryocytes was 65.63%,75.00%,and 100.00%;while in the megaloblastic anemia group,they were 3.13%,15.63%,6.25%,and 0.00%respectively,which were displayed great differences after comparisons(P<0.05).In the refractory anemia group,the diameters of megaloblastic pronormoblast and normoblast were(18.64±4.23)μm and(17.84±2.84)μm,which was shorter than(23.84±6.49)μm and(20.87±4.69)μm in the megaloblastic anemia group,with significant difference(P<0.05).Meanwhile,the red cell distribution width in the megaloblastic anemia group was(16.35±3.47)%,which was much lower than(28.94±7.22)%in the refractory anemia group,with significant difference(P<0.05).There was no significant difference in the level of hemoglobin,platelet and white blood cells between the two groups(P>0.05).ConclusionThe clinical value of morphological examination of bone marrow cells in refractory anemia and megaloblastic anemia is substantial,and is worthy of further promotion.
|
|
|
|
|
[1] |
何苗,赵强,韩燕霞,等.难治性贫血与巨幼细胞性贫血、再生障碍性贫血的细胞形态学对比分析[J].现代肿瘤医学,2016,24(11):1808-1812.
|
[2] |
Price E,Artz AS,Barnhart H,et al.A prospective randomized wait list control trial of intravenous iron sucrose in older adults with unexplained anemia and serum ferritin 20-200 ng/ml[J].Blood Cells Mol Dis,2014,53(4):221-230.
|
[3] |
刘雁,申红.难治性贫血与慢性再生障碍性贫血的临床与形态学分析[J].现代预防医学,2014,41(18):3430-3432.
|
[4] |
吴芹,冯春艳.巨幼细胞性贫血与难治性贫血细胞形态学的鉴别诊断[J].卫生职业教育,2014,32(24):134-135.
|
[5] |
Lai M,De Stefano V,Landolfi R,et al.Autoimmune hemolytic anemia with gel-based immunohematology tests:neural network analysis[J].Immunol Res,2014,58(1):70-74.
|
[6] |
郭丽.流式细胞术定量检测骨髓细胞免疫表型异常对MDS患者诊断及预后的参考价值研究[J].临床和实验医学杂志,2017,16(2):190-193.
|
[7] |
吴敏,李以贵,聂大年,等.骨髓形态差异在巨幼细胞性贫血与难治性贫血鉴别诊断中的临床意义[J].中国实验血液学杂志,2016,24(3):801-805.
|
[8] |
余蓉晖.难治性贫血与巨幼细胞性贫血的骨髓形态检验对比观察[J].当代医学,2016,22(1):64-65.
|
[9] |
王志玲.巨幼细胞性贫血与难治性贫血的细胞形态学的鉴别[J].内蒙古医学杂志,2016,48(7):799-801.
|
[10] |
宋发谷,韩骏飞,周春.骨髓形态检验在难治性贫血与巨幼细胞性贫血鉴别诊断中的应用[J].航空航天医学杂志,2015,26(9):1091-1092.
|
[11] |
王恒.骨髓形态检验在难治性贫血与巨幼细胞性贫血鉴别诊断中的应用[J].医疗装备,2016,29(10):74.
|
[12] |
袁媛,卢光祥.难治性贫血与巨幼细胞性贫血的骨髓形态检验分析[J].哈尔滨医药,2014,34(3):231.
|
[13] |
钟青,许业栋.骨髓形态检验在难治性贫血与巨幼细胞性贫血鉴别诊断中的临床价值[J].中国医药科学,2016,6(7):172-174.
|
[14] |
程虹,江明,杜伟,等.难治性贫血与其它贫血性疾病骨髓及血细胞形态学比较分析[J].中国实验血液学杂志,2012,20(6):1423-1426.
|
[15] |
包淑贞,张如峰,吴文英,等.难治性贫血与巨幼细胞性贫血的临床鉴别与诊断[J].现代预防医学,2011,38(18):3810-3811.
|
|
|
|